Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic versus proprietary alendronate in osteoporosis
ACTRN12613000329763Phase 4Completed
- Sponsor
- The University of Auckland
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of alendronate in osteoporosis (4 arms), sponsored by The University of Auckland. Primary endpoints: Change in serum beta-C telopeptides and Tolerability assessed by adverse events. Started Oct 2013; status: completed.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on ACTRN12613000329763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000329763.